Although there was no increase in drug intake, 42.8% (3/7) of patients reduced pregabalin intake by approximately 10%. Pain levels significantly declined and JFIQ significantly improved. The parameters for anxiety, depression, catastrophic thoughts, and sleep did not significantly change.